Which of the following is a true difference between gangliosides and cerebrosides?
Where does omega oxidation of fatty acids occur?
Which of the following fatty acids has the maximum number of carbon atoms?
Which of the following is monoenoic acid ?
In a person fasting overnight with carnitine deficiency, which of the following chemicals increase in quantity in blood?
What is the rate-controlling enzyme of fatty acid synthesis?
Which lipoprotein level is affected by LCAT deficiency?
Enzyme deficient in Type I Hyperlipidemia?
What is the role of Apoprotein C-II in lipid metabolism?
Which of the following is a lipotropic factor?
Explanation: ***Charge difference*** - **Gangliosides** contain **sialic acid (N-acetylneuraminic acid)** residues, which are negatively charged, making gangliosides **anionic**. - **Cerebrosides** are **neutral glycosphingolipids** as they lack charged sugar residues. *Specific carbohydrate composition* - While both have carbohydrate components, referring to "specific carbohydrate composition" as the *true difference* is too broad. Both have characteristic sugar groups, but the **presence of sialic acid** in gangliosides is the key differentiator in charge. - Cerebrosides typically contain a single sugar (either glucose or galactose), whereas gangliosides have a more complex oligosaccharide chain including sialic acid. *Presence of glucose* - Both cerebrosides (specifically **glucocerebrosides**) and gangliosides can contain **glucose** in their carbohydrate moieties. - This is not a distinguishing feature; the *type* and *arrangement* of sugars, particularly the presence of sialic acid, are more specific. *Location in the nervous system* - Both gangliosides and cerebrosides are abundant in the **nervous system**, particularly in cell membranes. - Their presence in the nervous system is a similarity, not a differentiating factor.
Explanation: ***Endoplasmic Reticulum*** - **Omega oxidation** of fatty acids occurs in the **endoplasmic reticulum (microsomes)** of liver and kidney cells. - This pathway involves **hydroxylation of the terminal omega carbon** by **cytochrome P450 enzymes** located in the smooth ER. - The omega carbon is then oxidized to a **carboxyl group**, forming a **dicarboxylic acid**. - This is a **minor pathway** that becomes important when **beta-oxidation is impaired** or for metabolism of **medium-chain fatty acids**. *Cytosol* - The cytosol is involved in **fatty acid synthesis**, not omega oxidation. - While some later steps of fatty acid metabolism occur in the cytosol, the initial hydroxylation step of omega oxidation requires ER-localized cytochrome P450 enzymes. *Mitochondria* - **Mitochondria** are the primary site for **beta-oxidation** of fatty acids, not omega oxidation. - Beta-oxidation sequentially removes **two-carbon units from the carboxyl end**, which is distinct from omega oxidation. - The dicarboxylic acids produced by omega oxidation may subsequently undergo beta-oxidation in mitochondria. *None of the options* - This option is incorrect because the endoplasmic reticulum is the correct cellular location for omega oxidation. - The ER contains the necessary cytochrome P450 enzymes for the hydroxylation reaction that initiates this pathway.
Explanation: **Cervonic acid** - **Cervonic acid**, also known as **docosahexaenoic acid (DHA)**, is a long-chain omega-3 fatty acid with **22 carbon atoms** and 6 double bonds (22:6). - It is a primary structural component of the brain and retina and is the longest fatty acid among the options provided. *Oleic acid* - **Oleic acid** is a monounsaturated fatty acid with **18 carbon atoms** and one double bond (18:1). - It is a common fatty acid found in many animal fats and vegetable oils, but it has fewer carbon atoms than cervonic acid. *Linolenic acid* - **Linolenic acid** refers to two essential fatty acids: alpha-linolenic acid (ALA) and gamma-linolenic acid (GLA). Both have **18 carbon atoms**. - Alpha-linolenic acid (ALA) is an omega-3 fatty acid with 3 double bonds (18:3), while gamma-linolenic acid (GLA) is an omega-6 fatty acid with 3 double bonds (18:3), neither of which has more carbon atoms than cervonic acid. *Arachidonic acid* - **Arachidonic acid** is an omega-6 fatty acid with **20 carbon atoms** and four double bonds (20:4). - It is a precursor to eicosanoids and is longer than oleic and linolenic acids but shorter than cervonic acid.
Explanation: ***Oleic acid*** - **Oleic acid** is a **monounsaturated fatty acid** (MUFA), meaning it has **one double bond** in its hydrocarbon chain. - Its presence in many natural fats and oils makes it a significant component of the human diet. *Arachidonic acid* - **Arachidonic acid** is a **polyunsaturated fatty acid** (PUFA) containing **four double bonds**. - It is a precursor for **eicosanoids**, including prostaglandins and leukotrienes, involved in inflammation and other physiological processes. *Linoleic acid* - **Linoleic acid** is an **essential omega-6 polyunsaturated fatty acid** with **two double bonds**. - It is crucial for human health and serves as a precursor for other fatty acids like arachidonic acid. *Linolenic acid* - **Linolenic acid** refers to two essential fatty acids: **alpha-linolenic acid (ALA)**, an omega-3 fatty acid with **three double bonds**, and **gamma-linolenic acid (GLA)**, an omega-6 fatty acid also with three double bonds. - Both are **polyunsaturated fatty acids** with multiple double bonds.
Explanation: ***Fatty acid levels*** - **Carnitine deficiency** impairs the transport of **long-chain fatty acids** into the mitochondria for beta-oxidation. - This leads to an accumulation of **fatty acids** in the blood as they cannot be efficiently metabolized for energy during fasting. - Therefore, **fatty acid levels increase** in the blood. *Ketone body levels* - **Ketone bodies** are produced from the **beta-oxidation of fatty acids** in the liver. - With **carnitine deficiency**, fatty acid oxidation is impaired, thus **reducing** the production of ketone bodies, not increasing them. *Glucose levels* - During **fasting**, the body relies on **gluconeogenesis** and **glycogenolysis** to maintain glucose levels. - With carnitine deficiency primarily affecting fat metabolism and preventing fatty acid utilization, the body cannot spare glucose effectively. - This leads to **hypoglycemia** (decreased glucose), not increased glucose levels. *Amino acid levels* - **Amino acid metabolism** is largely independent of **carnitine**. - While amino acids can be used for gluconeogenesis during fasting, carnitine deficiency does not directly cause an increase in circulating amino acid levels.
Explanation: ***Acetyl-CoA carboxylase*** - **Acetyl-CoA carboxylase (ACC)** catalyzes the committed step in fatty acid synthesis, converting **acetyl-CoA** to **malonyl-CoA**. - This enzyme is subject to both allosteric regulation (e.g., activation by **citrate** and inhibition by **long-chain fatty acyl-CoA**) and hormonal regulation (e.g., phosphorylation by glucagon and dephosphorylation by insulin). *Thioesterase* - **Thioesterase** is the enzyme responsible for releasing the completed fatty acid chain from the **fatty acid synthase complex**. - While essential for the termination of synthesis, it does not regulate the initiation or overall rate of the pathway. *Transacetylase* - **Transacetylase** (specifically, acetyl-CoA-ACP transacetylase and malonyl-CoA-ACP transacetylase) is involved in transferring acetyl and malonyl groups to the **acyl carrier protein (ACP)** within the fatty acid synthesis complex. - This is an intermediary step, but not the primary **rate-controlling** or committed step. *Ketoacyl synthase* - **Ketoacyl synthase (or β-ketoacyl-ACP synthase)** is responsible for condensing the growing acyl chain with malonyl-ACP, leading to the formation of a **β-ketoacyl-ACP**. - This is a crucial chain elongation step within the fatty acid synthase complex, but not the enzyme that controls the overall commitment to fatty acid synthesis.
Explanation: ***HDL*** - **LCAT (Lecithin-cholesterol acyltransferase)** is crucial for the maturation of **HDL (High-Density Lipoprotein)**. - LCAT esterifies cholesterol in HDL, enabling it to accept more free cholesterol from peripheral tissues, thus a deficiency leads to dysfunctional and decreased mature HDL. *LDL* - **LDL (Low-Density Lipoprotein)** formation primarily involves the breakdown of VLDL and IDL by lipoprotein lipase and hepatic lipase, not directly LCAT activity. - While an LCAT deficiency can indirectly affect lipid metabolism, its direct impact on LDL levels is less pronounced compared to HDL. *VLDL* - **VLDL (Very-Low-Density Lipoprotein)** is synthesized in the liver and transports triglycerides, with its metabolism being largely independent of LCAT. - LCAT's primary role is in **reverse cholesterol transport** and HDL maturation, not VLDL synthesis or catabolism. *Chylomicron* - **Chylomicrons** are formed in the intestines and transport dietary triglycerides and cholesterol, with their metabolism involving lipoprotein lipase. - LCAT does not directly affect the synthesis or breakdown of chylomicrons, which are primarily concerned with exogenous lipid transport.
Explanation: ***Lipoprotein lipase*** - **Type I hyperlipidemia**, also known as **familial hyperchylomicronemia**, is characterized by a deficiency in **lipoprotein lipase (LPL)**. - LPL is crucial for hydrolyzing triglycerides in **chylomicrons** and **VLDLs** into fatty acids and glycerol, allowing their uptake by tissues. *HMG CoA reductase* - This enzyme is involved in the **rate-limiting step of cholesterol synthesis** in the liver. - While it plays a role in lipid metabolism, its deficiency is not characteristic of **Type I hyperlipidemia**. *Peroxidase* - **Peroxidase** is an enzyme involved in various oxidative reactions, including the breakdown of **hydrogen peroxide**. - It is not directly involved in the metabolism of **chylomicrons** or **triglycerides**, and its deficiency is unrelated to hyperlipidemia. *Cholesterol acyl transferase* - This enzyme, often referring to **lecithin-cholesterol acyltransferase (LCAT)** or **acyl-CoA:cholesterol acyltransferase (ACAT)**, is involved in **cholesterol esterification**. - While important for cholesterol transport and storage, its deficiency is not the primary cause of **Type I hyperlipidemia**, which is marked by severe **chylomicronemia**.
Explanation: ***Activates lipoprotein lipase*** - **Apoprotein C-II (ApoC-II)** is a crucial **activator** of **lipoprotein lipase (LPL)**. - LPL is an enzyme responsible for **hydrolyzing triglycerides** from chylomicrons and VLDL, allowing fatty acids to be taken up by tissues. - **Deficiency of ApoC-II** leads to severe hypertriglyceridemia due to inability to activate LPL. *Inhibits lipoprotein lipase* - This is the function of **ApoC-III**, not ApoC-II. - ApoC-III **inhibits LPL activity**, which is the opposite role of ApoC-II. *Facilitates triglyceride transport* - While apoproteins are essential for **assembly and transport of lipoproteins** that carry triglycerides, this is not the specific primary role of ApoC-II. - ApoC-II's primary function is **regulating LPL enzyme activity**, not direct transport facilitation. *None of the options* - This is incorrect because ApoC-II clearly **activates lipoprotein lipase**, which is one of the given options.
Explanation: ***Methionine*** - **Methionine** is an essential amino acid that serves as a precursor for **choline** and **creatine**, both of which play crucial roles in lipid metabolism and transport. - Lipotropic factors prevent or reverse the accumulation of **fat in the liver** by promoting the synthesis of **lipoproteins**, which package and transport fats from the liver to other tissues. *Sphingomyelin* - **Sphingomyelin** is a type of **sphingolipid**, a component of cell membranes and myelin sheaths, but it does not directly act as a lipotropic factor to prevent fatty liver. - While it's involved in cellular signaling and membrane structure, it does not directly facilitate the metabolism or transport of **hepatic triglycerides** in the same way as lipotropic agents. *Histidine* - **Histidine** is an essential amino acid involved in protein synthesis and the production of **histamine**, but it is not considered a primary lipotropic factor. - Its main roles are in **immune response** and **neurotransmission**, not in preventing fat accumulation in the liver. *Bilirubin* - **Bilirubin** is a waste product from the breakdown of **heme**, primarily from red blood cells. It is excreted by the liver. - It is known for its **antioxidant properties** but does not play a direct role as a lipotropic factor in lipid metabolism or in preventing **fatty liver**.
Lipid Classification and Chemistry
Practice Questions
Fatty Acid Oxidation
Practice Questions
Ketone Body Metabolism
Practice Questions
Fatty Acid Synthesis
Practice Questions
Metabolism of Triacylglycerols
Practice Questions
Phospholipid Metabolism
Practice Questions
Cholesterol Metabolism and Biosynthesis
Practice Questions
Bile Acids and Bile Salts
Practice Questions
Lipoprotein Metabolism and Transport
Practice Questions
Dyslipidemias and Atherosclerosis
Practice Questions
Prostaglandins and Eicosanoids
Practice Questions
Fatty Liver and Lipotropic Factors
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free